Immuron (IMRN) Change in Account Payables (2016 - 2023)
Immuron's quarterly Change in Account Payables came in at -$6.3 million in Q4 2023, down 1501.45% quarter-over-quarter from $451865.3 in Q2 2021.
Immuron has reported Change in Account Payables for 5 years, with the latest figure at -$6.3 million in Q4 2023.
- For the quarter ending Q4 2023, Change in Account Payables changed N/A year-over-year to -$6.3 million; the trailing twelve-month figure through Dec 2023 stood at -$9.5 million (changed N/A YoY), and the FY2025 full-year result was -$393036.6, down 167.33% from the prior year.
- Change in Account Payables for Q4 2023 stood at -$6.3 million, down from $451865.3 in the prior quarter.
- The five-year high for Change in Account Payables was $451865.3 in Q2 2021, with the low at -$6.3 million in Q4 2023.
- Average Change in Account Payables over 3 years is -$2.0 million, with a median of -$237548.7 recorded in 2020.
- Peak annual rise in Change in Account Payables reached 290.22% in 2021, while the deepest fall reached 290.22% in 2021.
- Tracing IMRN's Change in Account Payables over 3 years: stood at -$237548.7 in 2020, then surged by 290.22% to $451865.3 in 2021, then slumped by 1501.45% to -$6.3 million in 2023.
- The last three Change in Account Payables figures came in at -$6.3 million (Q4 2023), $451865.3 (Q2 2021), and -$237548.7 (Q2 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Immuron | 1.27 Bn | 1.27 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -6.33 Mn |
| Dec 31, 2023 | -6.33 Mn |
| Jun 30, 2021 | 451,865.28 |
| Jun 30, 2021 | 451,865.28 |
| Jun 30, 2020 | -237,548.69 |
| Jun 30, 2020 | -237,548.69 |
| Dec 31, 2017 | -3.40 Mn |
| Dec 31, 2017 | -3.40 Mn |
| Dec 31, 2016 | 3.34 Mn |
| Dec 31, 2016 | 3.34 Mn |